Recombinant Mouse IL-13 R alpha 2 Fc Chimera Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 539-IR

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
539-IR-100
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

NS0

Accession #

O88786

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

View all IL-13 R alpha 2 Proteins and Enzymes »

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse IL-13 R alpha 2 protein
Mouse IL-13 R alpha2
(Leu22 - Lys334)
Accession # O88786		 IEGRDID Human IgG1
(Pro100 - Lys330)
N-terminus C-terminus

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Leu22

Predicted Molecular Mass

63 kDa (monomer)

SDS-PAGE

85-90 kDa, reducing conditions

Activity

Measured by its ability to inhibit IL-13-dependent proliferation of TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323.
The ED50 for this effect is 0.01-0.03 µg/mL in the presence of 8 ng/mL of recombinant mouse IL-13.

Formulation, Preparation and Storage

539-IR
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 100 μg/mL in sterile PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IL-13 R alpha 2

Interleukin-13 Receptor alpha 2 (IL-13 Ra2), also known as IL-13 Ra’, IL-13 binding protein, and CD213a2, is a widely expressed 55 kDa cytokine receptor that plays an important role in the Th2‑polarized immune responses characteristic of a variety of pathologies including parasitic infections and allergic asthma (1, 2). Mature mouse IL-13 Ra2 consists of a 313 amino acid (aa) extracellular domain with three fibronectin type-III domains, a WSxWS motif, a 21 aa transmembrane segment, and a 28 aa cytoplasmic domain (3). Within the ECD, mouse IL-13 Ra2 shares 64% and 94% aa sequence identity with human and rat IL-13 Ra2, respectively. A 40 kDa ‑ 50 kDa soluble form of mouse IL-13 Ra2 can be generated by alternate splicing or MMP-8 mediated shedding (4, 5). The biological effects of IL-13 and IL-4 are closely related in part due to a shared receptor system. IL‑13 binds to IL-13 Ra1 which then forms a signaling complex with IL-4 Ra (6, 7). IL-13 Ra2 functions as a decoy receptor by binding and internalizing IL-13 and preventing it from signaling through the IL-13 Ra1/IL-4 Ra complex (3, 8). IL‑13 Ra2 can also block IL-4 induced responses by inhibiting IL-4 bound IL-13 Ra1/IL-4 Ra receptor complexes even though it does not itself bind IL-4 (9, 10). Aside from its decoy function, IL‑13‑activated IL-13 Ra2 directly promotes the development of tissue fibrosis by inducing the transcription of TGF-beta (11). Soluble IL‑13 Ra2 retains ligand binding capability and attenuates responses to IL-13 but not to IL-4 (9, 12). The up‑regulation of transmembrane and soluble IL‑13 Ra2 during Th2-biased immune responses limits the extent of those responses (13 ‑ 15). IL‑13 Ra2 is expressed in some cancers, and its ability to block IL-13 and IL-4 contributes to tumorigenesis and metastasis (10, 16).

References

  1. Wynn, T.A. (2003) Annu. Rev. Immunol. 21:425.
  2. Tabata, Y. et al. (2007) Curr. Allergy Asthma Rep. 7:338.
  3. Donaldson, D.D. et al. (1998) J. Immunol. 161:2317.
  4. Tabata, Y. et al. (2006) J. Immunol. 177:7905.
  5. Chen, W. et al. (2008) J. Allergy Clin. Immunol. 122:625.
  6. Andrews, A.-L. et al. (2006) J. Immunol. 176:7456.
  7. Zurawski, S.M. et al. (1995) J. Biol. Chem. 270:13869.
  8. Caput, D. et al. (1996) J. Biol. Chem. 271:16921.
  9. Andrews, A.-L. et al. (2006) J. Allergy Clin. Immunol. 118:858.
  10. Rahaman, S.O. et al. (2002) Cancer Res. 62:1103.
  11. Fichtner-Feigl, S. et al. (2006) Nat. Med. 12:99.
  12. Zhang, J.G. et al. (1997) J. Biol. Chem. 272:9474.
  13. Chiaramonte, M.G. et al. (2003) J. Exp. Med. 197:687.
  14. Morimoto, M. et al. (2009) J. Immunol. 183:1934.
  15. Zheng, T. et al. (2008) J. Immunol. 180:522.
  16. Fujisawa, T. et al. (2009) Cancer Res. 69:8678.

Long Name

Interleukin 13 Receptor alpha 2

Alternate Names

CD213a2, IL-13Ra2, IL13R alpha 2, IL13RA2

Entrez Gene IDs

3598 (Human); 16165 (Mouse)

Gene Symbol

IL13RA2

UniProt

O88786

Additional IL-13 R alpha 2 Products

Product Documents for Recombinant Mouse IL-13 R alpha 2 Fc Chimera Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Mouse IL-13 R alpha 2 Fc Chimera Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.